EGFR and non-small cell lung carcinoma: In non-small-cell lung cancer (NSCLC) cells like A549 and H1975, these designed peptides promoted autophagy and enhanced endolysosomal degradation of the over-expressed cell surface oncogenic receptor epidermal growth factor receptor (EGFR), two processes that are Beclin 1-dependent [30].